1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. TREVI THERAPEUTICS INC
Trevi Therapeutics Inc XNAS: TRVI

Trevi Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary f...

Read More
8.54 0.56 (7.02%)
261.86% Gain from 52W Low
1.6M
XNAS Volume

XNAS 18 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
4.5 / 100
Momentum Score
Technically Bullish
70.6 / 100
Analyst Price Target
No estimates available

14

S

5

W

6

O

0

T

SWOT Analysis

Trevi Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..